bioXXmed AG (FRA:T5O)

Germany flag Germany · Delayed Price · Currency is EUR
1.330
+0.030 (2.31%)
At close: Jan 30, 2026
-65.63%
Market Cap361.58K -72.2%
Revenue (ttm)20.49K +310.4%
Net Income-890.91K
EPS-3.28
Shares Out271.87K
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5
Average Volume395
Open1.330
Previous Close1.300
Day's Range1.330 - 1.330
52-Week Range0.005 - 5.000
Beta1.12
RSI60.51
Earnings DateJun 26, 2026

About bioXXmed AG

bioXXmed AG, an investment company, invests in biotechnology or medical technology companies with equity or debt capital. It engages in the development of products for the diagnosis, alleviation, or cure of diseases through investments. The company was formerly known as CytoTools AG and changed its name to bioXXmed AG in September 2022. bioXXmed AG was founded in 2000 and is based in Heidelberg, Germany. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 1
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol T5O
Full Company Profile

Financial Performance

In 2024, bioXXmed AG's revenue was 3,493, a decrease of -79.93% compared to the previous year's 17,404. Losses were -996,907, -95.24% less than in 2023.

Financial Statements